SEC Form 4 · accession 0001209191-15-037682
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Durand
Officer — EVP & CFO
Period of report
Apr 29, 2015
Accepted (ET)
May 1, 2015 · 11:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $8.95 | Apr 29, 2015 | A | 120,000 | A | — | Apr 29, 2025 | Common Stock | 120,000 | 145,000 | D |
Explanation of responses
- F130,000 of the original number of shares subject to this option shall vest and become exercisable on April 29, 2016 and 1/36 of the remaining options shall vest following each one month period of service thereafter, subject to the reporting person's continued service to the Company through each such vesting date.